Avidity Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Avidity Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Avidity Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $14.1M, a 43.5% increase year-over-year.
  • Avidity Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $47.1M, a 31.9% increase year-over-year.
  • Avidity Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $38.2M, a 40.8% increase from 2022.
  • Avidity Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $27.1M, a 59.1% increase from 2021.
  • Avidity Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $17.1M, a 296% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $38.2M +$11.1M +40.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $27.1M +$10.1M +59.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $17.1M +$12.7M +296% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $4.31M +$3.9M +962% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $406K +$346K +577% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $60K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.